June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
AMP-activated Protein Kinase Suppresses Matrix Metalloproteinase-9 Expression and Cell Migration of Mouse Retinal Pigment Epithelium
Author Affiliations & Notes
  • Yuki Morizane
    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA
    Ophthalmology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  • Kimio Takeuchi
    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Jun Suzuki
    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Takeru Yoshimura
    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Yusuke Murakami
    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Maki Kayama
    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Fumiaki Kumase
    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Benoit Viollet
    INSERM, Paris, France
  • Joan Miller
    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Demetrios Vavvas
    Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Footnotes
    Commercial Relationships Yuki Morizane, None; Kimio Takeuchi, None; Jun Suzuki, None; Takeru Yoshimura, None; Yusuke Murakami, None; Maki Kayama, None; Fumiaki Kumase, None; Benoit Viollet, None; Joan Miller, Massachusetts Eye and Ear Infirmary (P), Novartis (I), Alcon (C), KalVista Pharmaceuticals (C); Demetrios Vavvas, MEEI (P), Kala pharmaceuticals (C), Roche (C), Genentech (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2016. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Yuki Morizane, Kimio Takeuchi, Jun Suzuki, Takeru Yoshimura, Yusuke Murakami, Maki Kayama, Fumiaki Kumase, Benoit Viollet, Joan Miller, Demetrios Vavvas; AMP-activated Protein Kinase Suppresses Matrix Metalloproteinase-9 Expression and Cell Migration of Mouse Retinal Pigment Epithelium. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2016.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Increased degradation of extracellular matrix by matrix metalloproteinases (MMPs) and aberrant migration of retinal pigment epithelium (RPE) are the important pathologic features of proliferative vitreoretinopathy (PVR). Recently, we reported that AMPK, a central regulator of energy homeostasis, suppresses MMP-9 expression in mouse embryonic fibroblasts (JBC 2011). In this study, we investigated the effect of AMPK activation on MMP-9 expression and cell migration of RPE.

Methods: We used primary RPEs isolated from AMPKα wild type (WT), AMPKα1 or α2 subunit single-knockout (AMPKα1-/- and AMPKα2-/-, respectively) mouse. RPEs were treated with TGFβ-2 with or without AMPK activator, 5-amino-4-imidazole carboxamide riboside (AICAR). The effects of AICAR on TGFβ-2 induced MMP-9 expression and cell migration were determined by zymography, ELISA, quantitative real time RT-PCR and chemoinvasion assay. The involvement of protein kinases such as ERK, JNK, p38 MAPK, and smad2/3 was investigated by western blotting.

Results: TGFβ-2 increased MMP-9 expression dose dependently and facilitated RPE migration. AMPK activation with AICAR significantly inhibited these TGFβ-2-elicited effects, whereas AICAR inhibitor (5-iodotubericidin, IODO) recovered them. In AMPKα1-/- RPE, the increasing rate of MMP-9 expression after TGFβ-2 stimulation was higher than that of WT RPE. In contrast, in AMPKα2-/- RPE, the increasing rate of MMP-9 expression was lower than WT RPE. Treatment with both TGFβ-2 and AICAR activated JNK pathway and pretreatment with IODO suppressed the JNK pathway. Consistently, the selective JNK inhibitor (SP600125) significantly and dose-dependently attenuated the inhibitory effect of AICAR on the TGFβ-2 induced MMP-9 expression.

Conclusions: Activation of AMPK suppresses TGFβ-2 induced MMP-9 expression and cell migration. The suppressive effect of AMPK activation may depend on AMPKα1 subunit rather than α2 subunit. These results suggest that AMPK can be a therapeutic target to inhibit aberrant RPE migration in PVR.

Keywords: 701 retinal pigment epithelium • 655 proliferative vitreoretinopathy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×